文献速递生殖医学产科

程序化冻融胚胎移植周期增加排卵妇女妊娠期高血压疾病风险:一项多中心队列研究

Programmed frozen embryo transfer cycle increased risk of hypertensive disorders of pregnancy: a multicenter cohort study in ovulatory women.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-09-15

这项在中国东南部5个生殖医学中心开展的回顾性队列研究,纳入2016至2019年间排卵规律、接受程序化或自然周期冻融囊胚移植并单胎活产(孕28周后)的妇女,比较两组围产结局。程序化周期组妊娠期高血压疾病(aOR 2.71,95%CI 1.59-4.91)和子痫前期(aOR 2.71,95%CI 1.17-6.23)风险高于自然周期组。作者结论认为程序化冻融胚胎移植与排卵妇女妊娠期高血压疾病风险升高相关。

要点

  • 程序化周期组妊娠期高血压疾病风险高于自然周期组(aOR 2.71,95%CI 1.59-4.91)。
  • 程序化周期组子痫前期风险高于自然周期组(aOR 2.71,95%CI 1.17-6.23)。
  • 激素替代联合促性腺激素释放激素类似物预处理亚组子痫前期风险最高(aOR 4.99,95%CI 1.94-12.82)。

核心结论

  • 在排卵妇女中,程序化冻融胚胎移植后妊娠与妊娠期高血压疾病风险升高相关。
  • 三种方案中,激素替代联合促性腺激素释放激素类似物预处理周期的子痫前期风险最高。

研究设计与样本

  • 中国东南部5个生殖医学中心开展的区域性多中心回顾性队列研究,纳入2016至2019年间月经周期规律(21-35天)、接受程序化或自然周期冻融囊胚移植且孕28周后单胎活产的患者,每名患者每队列仅纳入1个周期。
  • 研究样本包括自然周期冻融胚胎移植499例和程序化冻融胚胎移植900例。
  • 将冻融胚胎移植治疗周期与产科用药记录链接,并进行全面病历回顾以比较母婴结局,计算粗比值比和校正比值比(95%CI),并校正相关混杂因素。

主要发现

  • 程序化周期组妊娠期高血压疾病风险高于自然周期组(校正比值比2.71,95%CI 1.59-4.91)。
  • 程序化周期组子痫前期风险高于自然周期组(校正比值比2.71,95%CI 1.17-6.23)。
  • 两种内膜准备方案之间其他不良围产结局无显著差异。
  • 亚组分析中,激素替代治疗亚组和激素替代联合促性腺激素释放激素类似物预处理亚组妊娠期高血压疾病风险均高于自然周期组。
  • 激素替代联合促性腺激素释放激素类似物预处理亚组子痫前期风险高于其他两组(校正比值比4.99,95%CI 1.94-12.82;校正比值比2.47,95%CI 1.17-5.18)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although live birth rates were comparable between programmed and natural frozen-thawed embryo transfer cycles, recent data showed that pregnancies after programmed cycle were associated with an increased risk of adverse perinatal outcomes, such as hypertensive disorders of pregnancy. Such a difference might be attributed to selection bias because patients with ovulation disorders are more likely to receive programmed endometrial preparation protocol than natural cycle. OBJECTIVE: This study aimed to analyze whether programmed endometrial preparation protocol is associated with an increased risk of adverse perinatal outcomes compared with natural cycle during frozen embryo transfer in ovulatory women. STUDY DESIGN: This regional multicenter retrospective cohort study was conducted in 5 reproductive medical centers in Southeast China. Patients with regular cycles (21-35 days), who underwent either programmed or natural cycle blastocyst frozen embryo transfer and delivered singleton live birth babies after 28 weeks of gestation between 2016 and 2019 were analyzed. Each patient only contributed 1 cycle per cohort. The patients' frozen embryo transfer treatment cycles were linked to their obstetrical medication record, and a comprehensive medical record review was conducted to compare the maternal and neonatal outcomes between natural cycle and programmed cycle. Crude and adjusted odds ratios with 95% confidence intervals were calculated, and adjustment was made for relevant confounders. RESULTS: Study samples included 499 natural cycle frozen embryo transfer cases and 900 programmed frozen embryo transfer cases. Pregnancies after programmed cycle were associated with increased odds of hypertensive disorders of pregnancy (adjusted odds ratio, 2.71; 95% confidence interval, 1.59-4.91) and preeclampsia (adjusted odds ratio, 2.71; 95% confidence interval, 1.17-6.23) compared with pregnancies after natural cycle. No significant difference was detected regarding other adverse perinatal outcomes between the 2 endometrial protocols. In subgroup analysis, both the subgroups of hormone replacement therapy and hormone replacement therapy with gonadotrophin-releasing hormone analogue pretreatment had increased odds of developing hypertensive disorders of pregnancy than the natural cycle group. The risk of developing preeclampsia was higher in the hormone replacement therapy with gonadotrophin-releasing hormone analogue pretreatment subgroup than in the other 2 groups (adjusted odds ratio, 4.99; 95% confidence interval, 1.94-12.82) (aOR, 2.47; 95% CI, 1.17-5.18). CONCLUSION: Pregnancies after programmed frozen embryo transfer were associated with higher risks of hypertensive disorders of pregnancy in ovulatory women. The hormone replacement therapy with gonadotrophin-releasing hormone analogue pretreatment cycle led to the highest risk of preeclampsia among the 3 protocols.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Gu F, Wu Y, Tan M, et al. Programmed frozen embryo transfer cycle increased risk of hypertensive disorders of pregnancy: a multicenter cohort study in ovulatory women. Am J Obstet Gynecol MFM. 2022. PMID: 36115572. doi:10.1016/j.ajogmf.2022.100752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。